feed,title,long_url,short_url
Benzinga,"Biogen, Bio-Thera Ink Licensing Agreement For Development Of Actemra-Based Biosimilar For Rheumatoid Arthritis",https://benzinga.com/general/biotech/21/04/20540595/biogen-bio-thera-ink-licensing-agreement-for-development-of-actemra-based-biosimilar-for-rheumato,https://j.mp/3wDex9s
